Company Overview of Sitari Pharmaceuticals, Inc.
Sitari Pharmaceuticals, Inc. develops treatments for multiple disease indications such as celiac disease. The company offers targeted inhibitors of Transglutaminase 2 (TG2) with the potential to suppress the autoimmune response that results in intestinal inflammation and cell pathogenesis in celiac patients. Sitari Pharmaceuticals, Inc. was founded in 2013 and is based in San Diego, California.
San Diego, CA
Founded in 2013
Key Executives for Sitari Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Vetritionals, Inc.||United States|
|Anodyne Dental Pharma Inc.||United States|
|PEGUS Research, Inc.||United States|
|Cutanea Life Sciences, Inc.||United States|
|Charisela Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sitari Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.